News & Media
NasoNeb, Inc., a Trudell Medical Group company, is a global developer and manufacturer of intranasal drug delivery systems inspired by ENT clinics and designed with healthcare specialists in mind.
Oct 28, 2021
NasoNeb, Inc. (the “Company” or “NasoNeb”), a developer of innovative intranasal drug delivery and nasal care solutions, is proud to welcome Dr. Brian Rotenberg and Dr. Rodney Schlosser to the Company’s newly-formed Medical Advisory Board.Read More
May 1, 2019
DRUG STORE NEWS
Officials at NasoNeb felt that consumers were being offered inadequate nasal therapy delivery systems, so they developed a product that they believe stands above the crowd. Bill Flickinger, the company’s president, said that NasoNeb has a solid alternative in a conversation with Drug Store News.Read More
Mar 14, 2017
Medical Device Company Receives ISO and CMDCAS Certification; Signs First European Distributor
MedInvent, LLC, is pleased to announce CE Marking of its patented intranasal delivery device, the NasoNeb II Nasal Nebulizer, manufactured, marketed and sold in the United States since 2009. MedInvent is also pleased to announce its first EU distribution contract with Vedise Hospital in Rome, to market the NasoNeb System in Italy, San Marino and Vatican City. Vedise Hospital has marketed ENT products for over 20 years, serving Otolaryngologists in Italy.Read More
Mar 14, 2017
MedInvent, a company based in Medina, Ohio, received European CE Mark approval for its NasoNeb II Nasal Nebulizer. The device is intended for patients with chronic sinusitis and allergic rhinitis, delivering drugs (typically budesonide) into the nasal and paranasal sinus cavities.Read More
©2007-2021 NasoNeb, Inc., All rights reserved.